Loading data for TENX — first visit, this takes a few seconds.
Tenax Therapeutics Inc. (TENX)
NasdaqCM: TENX
· Real-Time Price · USD
2.13
-0.06 (-2.74%)
At close: Aug 28, 2026, 8:00 PM
2.15
+0.92%
After-hours: 5:45 PM
The price, the headline numbers and the latest news, in one place.
Tenax Therapeutics Inc. (TENX) Stock Price, Analysis & Data
-2.74% (1D)
No data available
| Bid | 1.64 |
| Market Cap | 79.71M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -64.86M |
| 0.93 | |
| -1.48 | |
| n/a | |
| -1.42 | |
| P/B (ttm) | 0.93 |
| P/S (ttm) | n/a |
| Earnings Date | n/a |
| Ask | 2.72 |
| Volume | 2,747,288 |
| Avg. Volume (20D) | 4,242,903 |
| Open | 2.16 |
| Previous Close | 2.19 |
| Day's Range | 2.12 - 2.29 |
| 52-Week Range | 1.31 - 19.40 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About TENX
Tenax Therapeutics, Inc., a development-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatmen...
Industry Biotechnology
Sector Healthcare
IPO Date Apr 4, 1994
Employees 14
Stock Exchange NasdaqCM
Ticker Symbol TENX
Website https://www.tenaxthera.com
Financial Performance
In 2025, Tenax Therapeutics's revenue was 0, an increase of undefined% compared to the previous year's 0. Earnings were -52.6M, an increase of 198.82%.
Financial StatementsEarnings Surprise
Tenax Therapeutics has released their quarterly earnings on Jul 31, 2026:
- Revenue of $0 misses estimates by $0, with NaN% YoY growth.
- EPS of -0.35 exceeds estimates by 0.01, with -29.63% YoY decline.
Page 1 of 2